And unlike a gym membership, there is no PMPM overhead, prior authorization process, or pissed off employees eating up HR time and budget
Most experts now recommend viewing these medications as long-term treatments rather than temporary interventions
Regional Outlook of GLP-1 Analogues Market As per the latest GLP-1 analogues market analysis, North America dominated in 2024, capturing a market share of 68.4%
Martin trained at the University of California, Irvine Hospital in family medicine, where he treated patients of all ages with obesity, diabetes, thyroid & hormone disorders, high blood pressure, age-related diseases, chronic pain, and autoimmune conditions
Tirzepatide, used in Zepbound and Mounjaro, targets both the GLP-1 and the GIP receptor agonist, while semaglutide, found in Wegovy and Ozempic, mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver
These GLP-1 receptor agonists can be categorized as either short-acting compounds, which provide short-lived receptor activation (such as exenatide and lixisenatide) or as long-acting compounds (for example albiglutide, dulaglutide, exenatide long-acting release, and liraglutide), which activate the GLP-1 receptor continuously at their recommended dose
